In vitro and in vivo characterization of the actin polymerizing compound chondramide as an angiogenic inhibitor.

Magdalena H Menhofer; Dominik Bartel; Johanna Liebl; Rebekka Kubisch; Johanna Busse; Ernst Wagner; Rolf Müller; Angelika M Vollmar; Stefan Zahler

doi:10.1093/cvr/cvu210

In vitro and in vivo characterization of the actin polymerizing compound chondramide as an angiogenic inhibitor.

Magdalena H Menhofer, Dominik Bartel, Johanna Liebl, Rebekka Kubisch, Johanna Busse, Ernst Wagner, Rolf Müller, Angelika M Vollmar, Stefan Zahler

Research output: Contribution to journal › Original Article › peer-review

5 Citations (Web of Science)

Original language	English
Pages (from-to)	303-314
Journal	CARDIOVASCULAR RESEARCH
Volume	104
Issue number	2
DOIs	https://doi.org/10.1093/cvr/cvu210
Publication status	Published - 2014

Keywords

ENDOTHELIAL-CELL MIGRATION
AGGRESOME FORMATION
RHO-FAMILY
SRC KINASE
F-ACTIN
CYTOSKELETON
AGENTS
DYNAMICS
JASPLAKINOLIDE
DISCOVERY

Access to Document

10.1093/cvr/cvu210

Cite this

Menhofer, M. H., Bartel, D., Liebl, J., Kubisch, R., Busse, J., Wagner, E., Müller, R., Vollmar, A. M., & Zahler, S. (2014). In vitro and in vivo characterization of the actin polymerizing compound chondramide as an angiogenic inhibitor. CARDIOVASCULAR RESEARCH , 104(2), 303-314. https://doi.org/10.1093/cvr/cvu210

Menhofer, Magdalena H ; Bartel, Dominik ; Liebl, Johanna et al. / In vitro and in vivo characterization of the actin polymerizing compound chondramide as an angiogenic inhibitor. In: CARDIOVASCULAR RESEARCH 2014 ; Vol. 104, No. 2. pp. 303-314.

@article{026946586f87403bab905c0d5645c73f,

title = "In vitro and in vivo characterization of the actin polymerizing compound chondramide as an angiogenic inhibitor.",

keywords = "ENDOTHELIAL-CELL MIGRATION, AGGRESOME FORMATION, RHO-FAMILY, SRC KINASE, F-ACTIN, CYTOSKELETON, AGENTS, DYNAMICS, JASPLAKINOLIDE, DISCOVERY",

author = "Menhofer, {Magdalena H} and Dominik Bartel and Johanna Liebl and Rebekka Kubisch and Johanna Busse and Ernst Wagner and Rolf M{\"u}ller and Vollmar, {Angelika M} and Stefan Zahler",

year = "2014",

doi = "10.1093/cvr/cvu210",

language = "English",

volume = "104",

pages = "303--314",

journal = "CARDIOVASCULAR RESEARCH ",

issn = "0008-6363",

number = "2",

}

Menhofer, MH, Bartel, D, Liebl, J, Kubisch, R, Busse, J, Wagner, E, Müller, R, Vollmar, AM & Zahler, S 2014, 'In vitro and in vivo characterization of the actin polymerizing compound chondramide as an angiogenic inhibitor.', CARDIOVASCULAR RESEARCH , vol. 104, no. 2, pp. 303-314. https://doi.org/10.1093/cvr/cvu210

In vitro and in vivo characterization of the actin polymerizing compound chondramide as an angiogenic inhibitor. / Menhofer, Magdalena H; Bartel, Dominik; Liebl, Johanna et al.
In: CARDIOVASCULAR RESEARCH , Vol. 104, No. 2, 2014, p. 303-314.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - In vitro and in vivo characterization of the actin polymerizing compound chondramide as an angiogenic inhibitor.

AU - Menhofer, Magdalena H

AU - Bartel, Dominik

AU - Liebl, Johanna

AU - Kubisch, Rebekka

AU - Busse, Johanna

AU - Wagner, Ernst

AU - Müller, Rolf

AU - Vollmar, Angelika M

AU - Zahler, Stefan

PY - 2014

Y1 - 2014

KW - ENDOTHELIAL-CELL MIGRATION

KW - AGGRESOME FORMATION

KW - RHO-FAMILY

KW - SRC KINASE

KW - F-ACTIN

KW - CYTOSKELETON

KW - AGENTS

KW - DYNAMICS

KW - JASPLAKINOLIDE

KW - DISCOVERY

U2 - 10.1093/cvr/cvu210

DO - 10.1093/cvr/cvu210

M3 - Original Article

C2 - 25239826

SN - 0008-6363

VL - 104

SP - 303

EP - 314

JO - CARDIOVASCULAR RESEARCH

JF - CARDIOVASCULAR RESEARCH

IS - 2

ER -

Menhofer MH, Bartel D, Liebl J, Kubisch R, Busse J, Wagner E et al. In vitro and in vivo characterization of the actin polymerizing compound chondramide as an angiogenic inhibitor. CARDIOVASCULAR RESEARCH . 2014;104(2):303-314. doi: 10.1093/cvr/cvu210